Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Pregnancy does not increase melanoma recurrence risk

DiSano JA et al. J Surg Res. 2018 Jun 16. doi: 10.1016/j.jss.2018.05.026.

Key clinical point: Pregnancy after melanoma does not appear to increase risk for melanoma recurrence.

Major finding: The rate of pregnancy for women with melanoma was 15.8%, compared with 13.6% for controls (P less than .001).

Study details: A retrospective study of claims database records on 11,801 women with melanoma and an equal number of matched controls.

Disclosures: The study was supported by a Barsumian Trust grant; the authors reported having no conflicts of interest.

Read the article.

Citation:

DiSano JA et al. J Surg Res. 2018 Jun 16. doi: 10.1016/j.jss.2018.05.026.

This Week's Must Reads

Broad opioid legislation advances in Congress, Senate floor debate, Sept. 17, 2018

Early supportive care cuts costs related to curative treatment, Koprowski CD et al. 2018 ASCO Quality Care Symposium, Abstract 142

Employee deductibles outstrip wages, Kaiser Family Foundation, 2018 Employer Health Benefits

The financial burden of metastatic breast cancer, Wheeler SB et al. Quality Care Symposium, Abstract 32

Must Reads in Melanoma

Nivolumab plus ipilimumab ups survival in melanoma patients with brain mets, Tawbi HA et al. N Engl J Med. 2018 Aug 23. doi: 10.1056/NEJMoa1805453

Pregnancy does not increase melanoma recurrence risk, DiSano JA et al. J Surg Res. 2018 Jun 16. doi: 10.1016/j.jss.2018.05.026.

FDA Approves First Treatment for Rare Skin Cancer, FDA news release; 2017 Mar 23

High-Dose Interferon vs Observation for Melanoma , J Clin Oncol; ePub 2017 Jan 30; Agarwala, et al

Trends in US Melanoma Incidence and Mortality, JAMA Dermatol; ePub 2016 Dec 21; Glazer, et al